Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001683168-25-006986
Filing Date
2025-09-15
Accepted
2025-09-15 16:02:03
Documents
1
Period of Report
2025-09-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4228
  Complete submission text file 0001683168-25-006986.txt   5770
Mailing Address 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406
Business Address 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406 (508) 767-3861
Phio Pharmaceuticals Corp. (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 453215903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752
Business Address
Ferrara Robert L (Reporting) CIK: 0001792987 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36304 | Film No.: 251314310